RPSE Res.Phm.Reg S

RNS Number:3196T
Research Pharmaceutical SRV, Inc
29 April 2008

29 April 2008

                     ReSearch Pharmaceutical Services, Inc.

                               10K Amended Filing

ReSearch Pharmaceutical Services, Inc. (the "Company") advises that it has
released an amended version of the annual 10K filing (10-K/A).

The Company is filing this Amendment No. 1 to its Annual Report on Form 10-K for
the fiscal year ended December 31, 2007, which was originally filed with the
Securities and Exchange Commission on March 20, 2008. We are amending the 2007
10-K to include additional information required to be filed by April 29, 2008.
The amended 10K does not change our previously reported financial statements or
the other financial disclosures contained in our originally filing.

The 10K/A filing can be found posted on our website www.rpsweb.com.

Enquires:

ReSearch Pharmaceutical Services, Inc.:                   +1-215-540-0700
Daniel M. Perlman, Chairman & Chief Executive Officer
Steven Bell, Chief Financial Officer

Nominated Adviser and UK Broker:                          +44-20-7012-2000
Arbuthnot Securities Limited
James Steel/Richard Tulloch


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCSEWSUUSASELL

Res.Phm.Reg S (LSE:RPSE)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024

Res.Phm.Reg S (LSE:RPSE)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024